FDPS and metabolic dysfunction-associated steatohepatitis: Excessive FDPS expression leads to heightened disease severity in NASH by increasing farnesyl pyrophosphate levels, which enhance CD36 expression and accelerate the development of NASH through lipid accumulation, inflammation, and fibrosis (Liu et al., 2023).